Abstract
Adenosine is a naturally occurring nucleoside, which exerts its biological effects by interacting witha family of adenosine receptors known as A1, A2A, A2B, and A3. The A2B subtype is a low affinity receptor,which couples to stimulation of adenylyl cyclase and also leads to a rise in intracellular calcium modulatingimportant physiological processes. Adenosine exhibiting activity at this subtype is at concentrations greaterthan 10 μM. The A2B receptors show a ubiquitous distributions, the highest levels are present in cecum, colonand bladder, followed by blood vessels, mast cells and lung. Through A2B receptors, adenosine also regulatesthe growth of smooth muscle cell populations in blood vessels, cell growth, intestinal function, inhibition ofTumor Necrosis Factor (TNF-α), vascular tone, and inflammatory processes such as diarrhea and asthma. Potent and selective adenosine agonists are the result of modifications of the parent ligand adenosine bysubstitution, namely at N6 or C2 position of the purine heterocycle or at the 5 position of the ribose moiety.5-N-ethylcarboxamidoadenosina (NECA) is one of the most potent A2B adenosine receptor agonist. Classicalantagonists for A2B adenosine receptors are xanthine analogues obtained from multiple substitutions of theparent heterocycle by C8 substitution combined with N1 and N3 (and sometimes N7) substitutions.
Keywords: Adenosine, A2B receptors, A2B agonists, A2B antagonists, Xanthines, Inflammation, Asthma
Current Medicinal Chemistry
Title: Ligands for A2B Adenosine Receptor Subtype
Volume: 13 Issue: 28
Author(s): Pier Giovanni Baraldi, Romeo Romagnoli, Delia Preti, Francesca Fruttarolo, Maria DoraCarrion and Mojgan Aghazadeh Tabrizi
Affiliation:
Keywords: Adenosine, A2B receptors, A2B agonists, A2B antagonists, Xanthines, Inflammation, Asthma
Abstract: Adenosine is a naturally occurring nucleoside, which exerts its biological effects by interacting witha family of adenosine receptors known as A1, A2A, A2B, and A3. The A2B subtype is a low affinity receptor,which couples to stimulation of adenylyl cyclase and also leads to a rise in intracellular calcium modulatingimportant physiological processes. Adenosine exhibiting activity at this subtype is at concentrations greaterthan 10 μM. The A2B receptors show a ubiquitous distributions, the highest levels are present in cecum, colonand bladder, followed by blood vessels, mast cells and lung. Through A2B receptors, adenosine also regulatesthe growth of smooth muscle cell populations in blood vessels, cell growth, intestinal function, inhibition ofTumor Necrosis Factor (TNF-α), vascular tone, and inflammatory processes such as diarrhea and asthma. Potent and selective adenosine agonists are the result of modifications of the parent ligand adenosine bysubstitution, namely at N6 or C2 position of the purine heterocycle or at the 5 position of the ribose moiety.5-N-ethylcarboxamidoadenosina (NECA) is one of the most potent A2B adenosine receptor agonist. Classicalantagonists for A2B adenosine receptors are xanthine analogues obtained from multiple substitutions of theparent heterocycle by C8 substitution combined with N1 and N3 (and sometimes N7) substitutions.
Export Options
About this article
Cite this article as:
Giovanni Baraldi Pier, Romagnoli Romeo, Preti Delia, Fruttarolo Francesca, DoraCarrion Maria and Aghazadeh Tabrizi Mojgan, Ligands for A2B Adenosine Receptor Subtype, Current Medicinal Chemistry 2006; 13 (28) . https://dx.doi.org/10.2174/092986706779010306
DOI https://dx.doi.org/10.2174/092986706779010306 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug Targets Contemporary Overview on Clinical Trials and Future Prospects of Hepato-protective Herbal Medicines
Reviews on Recent Clinical Trials Is Asthma Caused by Atopy (Positive Skin Prick Tests)? Epidemiologic Evidence Suggests a Negative Answer
Inflammation & Allergy - Drug Targets (Discontinued) The Use of Propolis in Micro/Nanostructured Pharmaceutical Formulations
Recent Patents on Drug Delivery & Formulation Isolation and Characterisation of Acetylcholinesterase Inhibitors from Aquilaria subintegra for the Treatment of Alzheimer’s Disease (AD)
Current Alzheimer Research Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment
Current Medicinal Chemistry Subtype Selectivity in Phosphodiesterase 4 (PDE4): A Bottleneck in Rational Drug Design
Current Pharmaceutical Design Calix[n]arenes as Goldmines for the Development of Chemical Entities of Pharmaceutical Interest
Current Pharmaceutical Design Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery Small Molecule CXCR4 Chemokine Receptor Antagonists: Developing Drug Candidates
Current Medicinal Chemistry Trafficking Potentials of Unconventional T Cell Subsets
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents New Computational Tool Based on Machine-learning Algorithms for the Identification of Rhinovirus Infection-Related Genes
Combinatorial Chemistry & High Throughput Screening Patent Selections
Recent Patents on Biotechnology Targeting T-Cell Adhesion Molecules for Drug Design
Current Pharmaceutical Design Hypertension in Pregnancy: Clinical Manifestations and Treatment
Current Hypertension Reviews Natural Products as Anti-glycation Agents: Possible Therapeutic Potential for Diabetic Complications
Current Diabetes Reviews Development of an Optimized Protein Chip for the Detection of Fish Parvalbumin Allergen
Current Analytical Chemistry Sequence Variants of the Ligand-Binding Domain of the Glucocorticoid Receptor Gene and their Functional Consequences on the Three- Dimensional Protein Structure
Current Medicinal Chemistry The Shift in the “Paradigm” of the Pharmacology of Hypertension
Current Topics in Medicinal Chemistry Absolute Blood Eosinophil Counts to Guide Inhaled Corticosteroids Therapy Among Patients with COPD: Systematic Review and Meta-analysis
Current Drug Targets